留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

感染性急性肾损伤:几个热点问题的冷思考

陈秀凯 杨荣利

陈秀凯, 杨荣利. 感染性急性肾损伤:几个热点问题的冷思考[J]. 协和医学杂志, 2017, 8(6): 336-341. doi: 10.3969/j.issn.1674-9081.2017.06.004
引用本文: 陈秀凯, 杨荣利. 感染性急性肾损伤:几个热点问题的冷思考[J]. 协和医学杂志, 2017, 8(6): 336-341. doi: 10.3969/j.issn.1674-9081.2017.06.004
Xiu-kai CHEN, Rong-li YANG. Septic Acute Kidney Injury: a Calm Thinking about the Hot Topics[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(6): 336-341. doi: 10.3969/j.issn.1674-9081.2017.06.004
Citation: Xiu-kai CHEN, Rong-li YANG. Septic Acute Kidney Injury: a Calm Thinking about the Hot Topics[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(6): 336-341. doi: 10.3969/j.issn.1674-9081.2017.06.004

感染性急性肾损伤:几个热点问题的冷思考

doi: 10.3969/j.issn.1674-9081.2017.06.004
详细信息
    通讯作者:

    陈秀凯 电话:+14126233276, E-mail:xic91@pitt.edu

  • 中图分类号: R459.7;R692

Septic Acute Kidney Injury: a Calm Thinking about the Hot Topics

More Information
    Corresponding author: CHEN Xiu-kai Tel: +14126233276, E-mail:xic91@pitt.edu
  • 摘要: 感染性急性肾损伤是重症患者急性肾损伤最常见的类型。本文结合《第3版全身性感染与感染性休克定义国际共识》、大数据、精准医疗、新型生物标志物、血流动力学治疗、重症血液净化等热点, 深入探讨如何正确理解以上热点问题, 以推动感染性急性肾损伤的研究并把先进理念落到临床工作实处。
  • [1] Peng Q, Zhang L, Ai Y, et al. Epidemiology of acute kidney injury in intensive care septic patients based on the KDIGO guidelines[J]. Chin Med J (Engl), 2014, 127:1820-1826. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhcmj201410005
    [2] Chang JW, Jeng MJ, Yang LY, et al. The epidemiology and prognostic factors of mortality in critically ill children with acute kidney injury in Taiwan[J]. Kidney Int, 2015, 87:632-639. doi:  10.1038/ki.2014.299
    [3] Parmar A, Langenberg C, Wan L, et al. Epidemiology of septic acute kidney injury[J]. Curr Drug Targets, 2009, 10:1169-1178. doi:  10.2174/138945009789753183
    [4] Kashani K, Shao M, Li G, et al. No increase in the incidence of acute kidney injury in a population-based annual temporal trends epidemiology study[J]. Kidney Int, 2017, 92:721-728. doi:  10.1016/j.kint.2017.03.020
    [5] 刘大为. Sepsis-3还告诉了我们什么?[J].中华危重病急救医学, 2017, 29:97-98. doi:  10.3760/cma.j.issn.2095-4352.2017.02.001
    [6] Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury[J]. Crit Care, 2013, 17:R25. doi:  10.1186/cc12503
    [7] Gist KM, Goldstein SL, Wrona J, et al. Kinetics of the cell cycle arrest biomarkers (TIMP-2*IGFBP-7) for prediction of acute kidney injury in infants after cardiac surgery[J]. Pediatr Nephrol, 2017, 22:1611-1619. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=a812c3146df00898e62b65b60582e0c8
    [8] Meersch M, Schmidt C, Hoffmeier A, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers:the PrevAKI randomized controlled trial[J]. Intensive Care Med, 2017.DOI: 10.1007/s00134-016-4670-3.
    [9] Schanz M, Shi J, Wasser C, et al. Urinary[TIMP-2]×[IGFBP7] for risk prediction of acute kidney injury in decompensated heart failure[J].Clin Cardiol, 2017, 40:485-491. doi:  10.1002/clc.22683
    [10] Bell M, Larsson A, Venge P, et al. Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury[J]. Dis Markers, 2015, 2015:158658. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=Doaj000004258485
    [11] Beitland S, Waldum-Grevbo BE, Nakstad ER, et al. Urine biomarkers give early prediction of acute kidney injury and outcome after out-of-hospital cardiac arrest[J]. Crit Care, 2016, 20:314. doi:  10.1186/s13054-016-1503-2
    [12] Honore PM, Nguyen HB, Gong M, et al. Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 for risk stratification of acute kidney injury in patients with sepsis[J]. Crit Care Med, 2016, 44:1851-1860. doi:  10.1097/CCM.0000000000001827
    [13] Bihorac A, Chawla LS, Shaw AD, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication[J]. Am J Respir Crit Care Med, 2014, 189:932-939. doi:  10.1164/rccm.201401-0077OC
    [14] Hoste EA, McCullough PA, Kashani K, et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers[J]. Nephrol Dial Transplant, 2014, 29:2054-2061. doi:  10.1093/ndt/gfu292
    [15] Vijayan A, Faubel S, Askenazi DJ, et al. Clinical use of the urine biomarker[TIMP-2]×[IGFBP7] for acute kidney injury risk assessment[J]. Am J Kidney Dis, 2016, 68:19-28. doi:  10.1053/j.ajkd.2015.12.033
    [16] Basu RK, Wong HR, Krawczeski CD, et al. Combining functional and tubular damage biomarkers improves diagnostic precision for acute kidney injury after cardiac surgery[J]. J Am Coll Cardiol, 2014, 64:2753-2762. doi:  10.1016/j.jacc.2014.09.066
    [17] Basu RK, Kaddourah A, Terrell T, et al. Assessment of worldwide acute kidney injury, renal angina and epidemiology in critically ill children (AWARE):a prospective study to improve diagnostic precision[J]. J Clin Trials, 2015, 5:222. http://cn.bing.com/academic/profile?id=164e7b05a3eeb5c48b0a0fdf9fea1e87&encoded=0&v=paper_preview&mkt=zh-cn
    [18] Chou YH, Chen YF, Pan SY, et al. The role of brain natriuretic peptide in predicting renal outcome and fluid management in critically ill patients[J]. J Formos Med Assoc, 2015, 114:1187-1196. doi:  10.1016/j.jfma.2015.10.015
    [19] Bagshaw SM, Chakravarthi MR, Ricci Z, et al. Precision continuous renal replacement therapy and solute control[J]. Blood Purif, 2016, 42:238-247. doi:  10.1159/000448507
    [20] Cerdá J, Baldwin I, Honore PM, et al. Role of technology for the management of AKI in critically ill patients:from adoptive technology to precision continuous renal replacement therapy[J]. Blood Purif, 2016, 42:248-265. doi:  10.1159/000448527
    [21] Frank AJ, Sheu CC, Zhao Y, et al. BCL2 genetic variants are associated with acute kidney injury in septic shock[J]. Crit Care Med, 2012, 40:2116-2123. doi:  10.1097/CCM.0b013e3182514bca
    [22] Vilander LM, Kaunisto MA, Vaara ST, et al. Genetic variants in SERPINA4 and SERPINA5, but not BCL2 and SIK3 are associated with acute kidney injury in critically ill patients with septic shock[J]. Crit Care, 2017, 21:47. doi:  10.1186/s13054-017-1631-3
    [23] Kaushal GP, Shah SV. Autophagy in acute kidney injury[J]. Kidney Int, 2016, 89:779-791. doi:  10.1016/j.kint.2015.11.021
    [24] Cardinal-Fernández P, Ferruelo A, El-Assar M, et al. Genetic predisposition to acute kidney injury induced by severe sepsis[J]. J Crit Care, 2013, 28:365-370. doi:  10.1016/j.jcrc.2012.11.010
    [25] Askenazi DJ, Halloran B, Patil N, et al. Genetic polymorphisms of heme-oxygenase 1(HO-1) may impact on acute kidney injury, bronchopulmonary dysplasia, and mortality in premature infants[J]. Pediatr Res, 2015, 77:793-798. doi:  10.1038/pr.2015.44
    [26] Abrahams E, Eck SL. Molecular medicine:precision oncology is not an illusion[J]. Nature, 2016, 539:357. http://cn.bing.com/academic/profile?id=e9c9eeb89a435fb0a169383ff7280576&encoded=0&v=paper_preview&mkt=zh-cn
    [27] Tannock IF, Hickman JA. Limits to personalized cancer medi-cine[J]. N Engl J Med, 2016, 375:1289-1294. doi:  10.1056/NEJMsb1607705
    [28] Bellomo R, Kellum JA, Ronco C, et al. Acute kidney injury in sepsis[J]. Intensive Care Med, 2017, 43:816-828. doi:  10.1007/s00134-017-4755-7
    [29] Gomez H, Ince C, De Backer D, et al. A unified theory of sepsis-induced acute kidney injury:inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury[J]. Shock, 2014, 41:3-11. http://cn.bing.com/academic/profile?id=52f41c420121ab63332ed1e5949f45f9&encoded=0&v=paper_preview&mkt=zh-cn
    [30] 陈秀凯, 李素玮, 刘大为, 等.中心静脉压在感染性休克所致急性肾损伤中的作用[J].中华医学杂志, 2011, 91:1323-1327. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyx201119009
    [31] 陈秀凯, 杨荣利, 刘大为.救治急性肾损伤:允许性低滤过与血液净化[J].中华内科杂志, 2014, 53:428-430. doi:  10.3760/cma.j.issn.0578-1426.2014.06.002
    [32] Honore PM, Jacobs R, Hendrickx I, et al. Prevention and treatment of sepsis-induced acute kidney injury:an update[J]. Ann Intensive Care, 2015, 5:51. doi:  10.1186/s13613-015-0095-3
    [33] McIntyre L, Rowe BH, Walsh TS, et al. Multicountry survey of emergency and critical care medicine physicians' fluid resuscitation practices for adult patients with early septic shock[J]. BMJ Open, 2016, 6:e010041. doi:  10.1136/bmjopen-2015-010041
    [34] Joannes-Boyau O, Honore PM, Perez P, et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study):a multicentre randomized controlled trial[J]. Intensive Care Med, 2013, 39:1535-1546. doi:  10.1007/s00134-013-2967-z
    [35] Fujii T, Ganeko R, Kataoka Y, et al. Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock:a protocol for a systematic review and meta-analysis[J]. BMJ Open, 2016, 6:e012908. doi:  10.1136/bmjopen-2016-012908
    [36] Chang T, Tu YK, Lee CT, et al. Effects of polymyxin B hemoperfusion on mortality in patients with severe sepsis and septic shock:a systemic review, meta-analysis update, and disease severity subgroup meta-analysis[J]. Crit Care Med, 2017, 45:e858-e858, e864. doi:  10.1097/CCM.0000000000002362
    [37] 杨荣利, 陈秀凯, 王小亭, 等.重症血液净化:从连续肾脏替代治疗到集成技术[J].中华医学杂志, 2013, 93:2769-2771. doi:  10.3760/cma.j.issn.0376-2491.2013.35.001
    [38] Nusshag C, Weigand MA, Zeier M, et al. Issues of acute kidney injury staging and management in sepsis and critical illness:a narrative review[J]. Int J Mol Sci, 2017, 18:1387. doi:  10.3390/ijms18071387
    [39] Pérez-Fernández X, Sabater-Riera J, Sileanu FE, et al. Clini-cal variables associated with poor outcome from sepsis-associated acute kidney injury and the relationship with timing of initiation of renal replacement therapy[J]. J Crit Care, 2017, 40:154-160. doi:  10.1016/j.jcrc.2017.03.022
    [40] Sutherland SM, Chawla LS, Kane-Gill SL, et al. Utilizing electronic health records to predict acute kidney injury risk and outcomes:workgroup statements from the 15(th) ADQI Consensus Conference[J]. Can J Kidney Health Dis, 2016, 3:11. doi:  10.1186/s40697-016-0099-4
    [41] Sutherland SM, Goldstein SL, Bagshaw SM. Leveraging big data and electronic health records to enhance novel approaches to acute kidney injury research and care[J]. Blood Purif, 2017, 44:68-76. doi:  10.1159/000458751
    [42] Lachance P, Villeneuve PM, Rewa OG, et al. Association between e-alert implementation for detection of acute kidney injury and outcomes:a systematic review[J]. Nephrol Dial Transplant, 2017, 32:265-272. doi:  10.1093/ndt/gfx149.SP428
    [43] Bagshaw SM, Goldstein SL, Ronco C, et al. Acute kidney injury in the era of big data:the 15(th) Consensus Con-ference of the Acute Dialysis Quality Initiative (ADQI)[J]. Can J Kidney Health Dis, 2016, 3:5.
    [44] James MT, Hobson CE, Darmon M, et al. Applications for detection of acute kidney injury using electronic medical records and clinical information systems:workgroup statements from the 15(th) ADQI Consensus Conference[J]. Can J Kidney Health Dis, 2016, 3:9. doi:  10.1186/s40697-016-0100-2
    [45] Hoste EA, Kashani K, Gibney N, et al. Impact of electronica-lerting of acute kidney injury:workgroup statements from the 15(th) ADQI Consensus Conference[J]. Can J Kidney Health Dis, 2016, 3:10. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768416/
    [46] Siew ED, Basu RK, Wunsch H, et al. Optimizing administrative datasets to examine acute kidney injury in the era of big data:workgroup statement from the 15(th) ADQI Consensus Conference[J]. Can J Kidney Health Dis, 2016, 3:12. http://cn.bing.com/academic/profile?id=de2ed01e7d923a91cff6f72954ebc58b&encoded=0&v=paper_preview&mkt=zh-cn
    [47] Mehta R, Bihorac A, Selby NM, et al. Establishing a continuum of acute kidney injury-tracing AKI using data source linkage and long-term follow-up:Workgroup Statements from the 15th ADQI Consensus Conference[J]. Can J Kidney Health Dis, 2016, 3:13. http://cn.bing.com/academic/profile?id=c77f92d1999d30145122ad994713ace9&encoded=0&v=paper_preview&mkt=zh-cn
  • 加载中
计量
  • 文章访问数:  326
  • HTML全文浏览量:  63
  • PDF下载量:  101
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-07-21
  • 刊出日期:  2017-11-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!